Showing results (11-20 of 140) with videos related to
Sort By:
Pageof 14
Seminars in Pediatric Surgery|December 14, 2016
Management of desmoplastic small round cell tumorAndrea Hayes-Jordan, Michael P LaQuaglia, Shakeel ModakMedical and Pediatric Oncology|October 12, 2002
Disialoganglioside GD2 and a novel tumor antigen: potential targets for immunotherapy of desmoplastic small round cell tumorShakeel Modak, William Gerald, Nai-Kong V CheungJournal of Pediatric Hematology/Oncology|July 17, 2015
Trametinib-induced Left Ventricular Dysfunction in a Child With Relapsed NeuroblastomaShakeel Modak, Alfred Asante-Korang, Laurel J Steinherz, et al.Journal of Pediatric Hematology/Oncology|April 24, 2018
Romiplostim for Immune Thrombocytopenia in Neuroblastoma Patients Receiving ChemotherapyHannah Fassel, James B Bussel, Stephen S Roberts, et al.Cancer Immunology, Immunotherapy : CII|October 18, 2002
Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodiesNai-Kong V Cheung, Shakeel Modak, Andrew Vickers, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
Successful multifold dose escalation of anti-GD2 monoclonal antibody 3F8 in patients with neuroblastoma: a phase I studyBrian H Kushner, Kim Kramer, Shakeel Modak, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Camptothecin analogs (irinotecan or topotecan) plus high-dose cyclophosphamide as preparative regimens for antibody-based immunotherapy in resistant neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Irinotecan plus temozolomide for relapsed or refractory neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.Cancer|January 8, 2005
Five-day courses of irinotecan as palliative therapy for patients with neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.Pageof 14